Acute Liver Failure Secondary to Remdesivir in the Treatment of COVID-19.
ACG Case Rep J
; 9(10): e00866, 2022 Oct.
Article
in English
| MEDLINE | ID: covidwho-2056480
ABSTRACT
Remdesivir has been the mainstay of coronavirus disease 2019 treatment since the start of the severe acute respiratory syndrome coronavirus 2 pandemic. Despite its growing use, safety data are limited. We present the case of an elderly man with obesity and coronavirus disease 2019 who developed acute liver failure after initiation of remdesivir. This report broadens our knowledge of the side effect profile of remdesivir and discusses potential risk factors and an approach to remdesivir-induced liver failure. Our case also highlights the importance of monitoring hepatic function after initiation of therapy with remdesivir.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
ACG Case Rep J
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS